Bone marrow-derived progenitor cells contribute to lung remodelling after myocardial infarction

Cardiovascular Pathology

Volumn 16, Issue 6, 2007, Pages 321-328

  Dupuis, Jocelyn ^a,b   Préfontaine, Annick ^a   Villeneuve, Louis ^a   Ruel, Nathalie ^a   Lefebvre, Frédéric ^a   Calderone, Angelino ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cell differentiation; Heart failure; Myofibroblasts; Pulmonary circulation

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART INFARCTION; IRRADIATION; LUNG ALVEOLUS WALL; LUNG MODEL; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STEM CELL; WESTERN BLOTTING; WHOLE BODY RADIATION;

EID: 36048953049     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2007.04.006     Document Type: Article

References (28)

1. Gehlbach B., and Geppert E. The pulmonary manifestations of left heart failure. Chest 125 (2004) 669-682
2. Al-Rawas O., Carter R., Stevenson R., Naik S., and Wheatley D. The alveolar-capillary membrane diffusing capacity and the pulmonary capillary blood volume in heart transplant candidates. Heart 83 (2000) 156-160
3. Dimopoulou I., Daganou M., Tsintzas O., and Tzelepis G. Effects of severity of long-standing congestive heart failure on pulmonary function. Respir Med 92 (1998) 1321-1325
4. Mettauer B., Lampert E., Charloux A., et al. Lung membrane diffusing capacity, heart failure, and heart transplantation. Am J Cardiol 83 (1999) 62-67
5. Ravenscraft S., Gross C., Kubo S., et al. Pulmonary function after successful heart transplantation. One year follow-up. Chest 103 (1993) 54-58
6. Puri S., Baker B., Dutka D., Oakley C., Hughes J., and Cleland J. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation 91 (1995) 2769-2774
7. Agostoni P., Guazzi M., Bussotti M., Grazi M., Palermo P., and Marenzi G. Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. J Am Coll Cardiol 36 (2000) 1600-1604
8. Bussieres L., Pflugfelder P., Ahmad D., Taylor A., and Kostuk W. Evolution of resting lung function in the first year after cardiac transplantation. Eur Respir J 8 (1995) 959-962
9. Jasmin J., Calderone A., Leung T., Villeneuve L., and Dupuis J. Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan. Cardiovasc Res 58 (2003) 621-631
10. Huang W., Kingsbury M., Turner M., Donnelly J., Flores N., and Sheridan D. Capillary filtration is reduced in lungs adapted to chronic heart failure: morphological and haemodynamic correlates. Cardiovasc Res 49 (2001) 207-217
11. Kingsbury M., Huang W., Donnelly J., et al. Structural remodelling of lungs in chronic heart failure. Basic Res Cardiol 98 (2003) 295-303
12. Kapanci Y., Burgan S., Pietra G., Conne B., and Gabbiani G. Modulation of actin isoform expression in alveolar myofibroblasts (contractile interstitial cells) during pulmonary hypertension. Am J Pathol 136 (1990) 881-889
13. Guazzi M. Alveolar-capillary membrane dysfunction in chronic heart failure: pathophysiology and therapeutic implications. Clin Sci (Lond) 98 (2000) 633-641
14. Smith A., Cowburn P., Parker M., et al. Impaired pulmonary diffusion during exercise in patients with chronic heart failure. Circulation 100 (1999) 1406-1410
15. Dunsmore S., and Shapiro S. The bone marrow leaves its scar: new concepts in pulmonary fibrosis. J Clin Invest 113 (2004) 180-182
16. Hashimoto N., Jin H., Liu T., Chensue S., and Phan S. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 113 (2004) 243-252
17. Hakamata Y., Tahara K., Uchida H., et al. Green fluorescent protein-transgenic rat: a tool for organ transplantation research. Biochem Biophys Res Commun 286 (2001) 779-785
18. Jasmin J., Mercier I., Hnasko R., et al. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression. Cardiovasc Res 63 (2004) 747-755
19. Gao J., Dennis J., Muzic R., Lundberg M., and Caplan A. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169 (2001) 12-20
20. Kraitchman D., Tatsumi M., Gilson W., et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112 (2005) 1451-1461
21. Sims D. Diversity within pericytes. Clin Exp Pharmacol Physiol 27 (2000) 842-846
22. Lefebvre F., Prefontaine A., Calderone A., et al. Modification of the pulmonary renin-angiotensin system and lung structural remodelling in congestive heart failure. Clin Sci (Lond) 111 (2006) 217-224
23. Shi-Wen X., Chen Y., Denton C., et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 15 (2004) 2707-2719
24. Li W., Yu W., Quinlan J., Burke Z., and Tosh D. The molecular basis of transdifferentiation. J Cell Mol Med 9 (2005) 569-582
25. Ninomiya K., Takahashi A., Fujioka Y., Ishikawa Y., and Yokoyama M. Transforming growth factor-beta signaling enhances transdifferentiation of macrophages into smooth muscle-like cells. Hypertens Res 29 (2006) 269-276
26. Guazzi M., Reina G., Tumminello G., and Guazzi M. Alveolar-capillary membrane conductance is the best pulmonary function correlate of exercise ventilation efficiency in heart failure patients. Eur J Heart Fail 7 (2005) 1017-1022
27. Shah R., and Mitchell R. The role of stem cells in the response to myocardial and vascular wall injury. Cardiovasc Pathol 14 (2005) 225-231
28. Engelmann M., Theiss H., Hennig-Theiss C., et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol 48 (2006) 1712-1721